Motor nerve blockade potency and toxicity of non-racemic bupivacaine in rats

Acta Anaesthesiologica Scandinavica

Volumn 49, Issue 1, 2005, Pages 66-71

  Trachez, M M ^a   Zapata Sudo, G ^b   Moreira, O R ^c   Chedid, N G B ^b   Russo, V F T ^c   Russo, E M S ^c   Sudo, Roberto T ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Cristalia Prod Quim Farmaceut L   (Brazil)

Author keywords

Anesthesia; Bupivacaine; Enantiomers; Local anesthetic; Motor nerve block; Toxicity

Indexed keywords

BUPIVACAINE;

ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOTOXICITY; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENCY; ELECTROSTIMULATION; ENANTIOMER; GENERAL ANESTHESIA; HEART MUSCLE CONTRACTILITY; MOTOR ACTIVITY; MOTOR NERVE; MUSCLE TWITCH; NERVE BLOCK; NERVE CONDUCTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; HEART; ISOMETRIC CONTRACTION; LETHAL DOSE 50; MOTOR NEURONS; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; NERVE BLOCK; RATS; RATS, WISTAR; SCIATIC NERVE; STEREOISOMERISM;

EID: 13444256588     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2004.00536.x     Document Type: Article

References (17)

1. Calvey TN. Isomerism and anaesthetic drugs. Acta Anaesthesiol Scand 1995; 35 (suppl. 106): 83-90.
2. Aberg G. Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacol Toxicol 1972; 31: 273-86.
3. Huang YF, Prior ME, Mather LE, Veering BT. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 1998; 86: 797-809.
4. Cox CR, Checkets MR, Mackenzie N, Scott B, Bannister J. Comparison of S(-) bupivacaine with racemic (RS)-bupivacaine in supraclavicular brachial plexus block. Br J Anaesth 1998; 80: 594-8.
5. Alley EA, Kopacz DJ, McDonald SB, Liu SS. Hyperbaric spinal levobupivacaine: a comparison to racemic bupivacaine in volunteers. Anesth Analg 2002; 94: 188-93.
6. Luduena EP, Bocado EF, Tullar B. Optical isomers of mepivacaine and bupivacaine. Archint Pharmacodyn 1972; 200: 359-69.
7. Denson DD, Behbehani MM, Gregg RV. Enantiomer specifec effects of an intravenously administered arrhythmogenic dose of bupivacaine on neurones of the nucvleus tractus solitarius and the cardiovascular system in the anesthtized rat. Regional Anesth 1992; 17: 331-16.
8. Mazoit JX, Boico O, Samii K. Myocardial uptake of bupivacaine. II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in isolated perfused rabbit heart. Anesth Analg 1993; 77: 477-82.
9. Akerman B, Hellberg IB, Trossvik C. Primary evaluation of local anaesthetic properties of the amino amide agent ropivacaine (LEA 103). Acta Anaesthesiol Scand 1988; 32: 571-8.
10. Mazoit JX, Cao LS, Samii K. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-lacid glycoprotein. Differences between the two enantiomers are partly due to cooperativity. J Pharmacol Exp Ther 1996; 276: 109-15.
11. Lee-Son S, Wang GK, Concus A, Crill E, Strichatz G. Stereoseletive inhibition of neuronal sodium channels by local anesthetics. Anesthesiology 1992; 77: 324-35.
12. Moller RA, Covino BG. Cardiac electrophysiologic effects of lidocaine and bupivacaine. Anesth Analg 1988; 67: 107-14.
13. Kotelko DM, Shnider SM, Dailey PA et al. Bupivavaine-induced cardiac arrhythmias in sheep. Anesthesiology 1984; 60: 10-8.
14. 2+ channels. Anest Analg 2001; 92: 496-501.
15. Coyle DE, Porembka DT, Sehlhorst CS, Wan L. Echocardiographic evaluation of bupivacaine cardiotoxicity. Anesth Analg 1994; 78: 335-9.
16. Rossner KL, Freese KJ. Bupivacaine inhibition of 1-type calcium current in ventricular cardiomyocytes of hamster. Anestesiology 1997; 8: 926-34.
17. 2+ release channel of skeletal and cardiac muscle. Anesthesiology 1999; 90: 835-43.